Australian Pharmaceutical Industries Limited
Australian Pharmaceutical Industries Limited (API) is a leading player in the pharmaceutical and healthcare sector, headquartered in Australia. Established in 1910, API has evolved significantly, marking key milestones in its commitment to delivering quality health solutions across the nation.
With a strong presence in major operational regions, API focuses on wholesale distribution, retail pharmacy, and health and beauty products. Its core offerings include a diverse range of pharmaceuticals, over-the-counter medications, and personal care items, distinguished by their quality and accessibility.
API holds a prominent market position, recognised for its innovative approach and dedication to customer service. The company’s strategic partnerships and extensive distribution network further enhance its reputation as a trusted provider in the Australian healthcare landscape.
+22 vs industry average
Australian Pharmaceutical Industries Limited’s score of 61 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Australian Pharmaceutical Industries Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Australian Pharmaceutical Industries Limited yet.
Australian Pharmaceutical Industries Limited's reported carbon emissions
Australian Pharmaceutical Industries Limited (API) currently does not have specific emissions data available for the most recent year, as indicated by the absence of reported figures. However, it is important to note that API is a current subsidiary of Wesfarmers Limited, which may influence its climate commitments and emissions reporting.
As a subsidiary, API's climate initiatives and targets may be aligned with those of Wesfarmers Limited. Wesfarmers has been actively involved in sustainability efforts, including commitments to reduce carbon emissions and improve environmental performance across its operations. While specific reduction targets for API are not detailed, the overarching goals set by Wesfarmers may provide a framework for API's climate strategy.
API has not publicly disclosed any specific science-based targets (SBTi) or reduction initiatives at this time. The absence of a climate pledge or documented reduction targets suggests that API is still in the process of developing its climate action strategy.
In summary, while Australian Pharmaceutical Industries Limited does not currently report specific carbon emissions data or reduction targets, its affiliation with Wesfarmers Limited may play a significant role in shaping its future climate commitments and sustainability initiatives.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Australian Pharmaceutical Industries Limited’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Australian Pharmaceutical Industries Limited yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Australian Pharmaceutical Industries Limited yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project